UC Berkeley researchers develop new way to deliver drugs directly to the brain

Researchers at the University of California, Berkeley have developed a new way to deliver drugs directly to the brain, which could improve the treatment of a wide range of neurological disorders. The new method, called "targeted drug delivery," uses nanoparticles to carry drugs across the blood-brain barrier, which is a protective layer of cells that surrounds the brain and spinal cord. This barrier prevents most drugs from entering the brain, which can make it difficult to treat neurological disorders such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis.

UC Berkeley study finds that air pollution can damage the brain

A new study from the University of California, Berkeley has found that air pollution can damage the brain, even in healthy adults. The study, which was published in the journal JAMA Internal Medicine, found that people who lived in areas with high levels of air pollution had lower scores on tests of cognitive function, such as memory, attention, and language. The study also found that air pollution was linked to an increased risk of dementia and Alzheimer's disease.

UC Berkeley researchers develop new vaccine for Zika virus

Researchers at the University of California, Berkeley have developed a new vaccine for the Zika virus, which is a mosquito-borne virus that can cause birth defects. The new vaccine, which is called ZIKV-001, is based on a weakened form of the Zika virus. In a study published in the journal Nature Medicine, researchers found that ZIKV-001 was safe and effective in protecting monkeys from the Zika virus. The study also found that ZIKV-001 was able to protect pregnant monkeys from giving birth to babies with birth defects.